Florida Selects DiaCarta’s cfDNA Test to Detect Early Response of Cancer Treatment
The Florida Health Department will use DiaCarta's RadTox test for early detection of cancer treatment response and resistance.
The Florida Health Department will use DiaCarta's RadTox test for early detection of cancer treatment response and resistance.
Scientists have investigated how the Cpeb4 protein mediates the production of osteoclasts, which are involved in bone and joint diseases.
The Occupational Health and Safety Management System (ISO 45001) is one of the certification standards established by the ISO in 2018.
Genomenon, a genomic intelligence company, has launched Genomenon Curate-Pro, a rapid on-demand...
Read MoreRevvity’s platform enables labs to adopt molecular testing for spinal muscular atrophy and severe combined immunodeficiency in newborns.
Read MoreNew research shows blood tests used to hunt for cancer DNA may help detect cancers faster and guide the use of targeted therapies
Read MoreThe new qPCR system raises the bar for performance and usability while bridging the gap between research and in vitro diagnostics.
Read MoreBIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read MoreA special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MoreIllumina’s Global Health Access Initiative will support access to pathogen sequencing tools for public health in lower income countries.
Read MoreAnchorDx entered into a long-term collaboration with DiaCarta for product development and global commercialization in cancer screening.
Read MoreSequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MoreVeracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read MoreRoche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read MoreNew England Biolabs released the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform.
Read MoreAbbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MoreTwist Bioscience launched Twist Full Length Unique Dual Index Adapters to enable PCR-free whole genome sequencing and multiplexing at scale.
Read MoreInvestigators have developed an environmental risk score that assesses a person’s risk for developing ALS using a blood sample.
Read More